Y 3.T 22/2:2 C 82/2/case 23
|
The Safety, efficacy, and cost effectiveness of therapeutic apheresis |
1 |
Y 3.T 22/2:2 C 82/2/case 24
|
Variations in hospital length of stay their relationship to health outcomes / |
2 |
Y 3.T 22/2:2 C 82/2/CASE 25
|
Technology and learning disabilities / |
1 |
Y 3.T 22/2:2 C 82/2/case 25
|
Technology and learning disabilities |
1 |
Y 3.T 22/2:2 C 82/2/CASE 26
|
Assistive devices for severe speech impairments / |
1 |
Y 3.T 22/2:2 C 82/2/case 26
|
Assistive devices for severe speech impairments |
1 |
Y 3.T 22/2:2 C 82/2/CASE 27
|
Nuclear magnetic resonance imaging technology : a clinical, industrial, and policy analysis / |
1 |
Y 3.T 22/2:2 C 82/2/case 27
|
Nuclear magnetic resonance imaging technology a clinical, industrial, and policy analysis / |
1 |
Y 3.T 22/2:2 C 82/2/CASE 28
|
Intensive care units (ICUs) : clinical outcomes, costs, and decisionmaking / |
1 |
Y 3.T 22/2:2 C 82/2/case 28
|
Intensive care units (ICUs) clinical outcomes, costs, and decisionmaking / |
1 |
Y 3.T 22/2:2 C 82/2/CASE 29
|
The Boston elbow / |
1 |
Y 3.T 22/2:2 C 82/2/case 29
|
The Boston elbow |
1 |
Y 3.T 22/2:2 C 82/2/CASE 30
|
The market for wheelchairs : innovations and federal policy / |
1 |
Y 3.T 22/2:2 C 82/2/case 30
|
The market for wheelchairs innovations and federal policy / |
1 |
Y 3.T 22/2:2 C 82/2/CASE 31
|
The contact lens industry : structure, competition, and public policy / |
1 |
Y 3.T 22/2:2 C 82/2/case 31
|
The contact lens industry structure, competition, and public policy / |
1 |
Y 3.T 22/2:2 C 82/2/CASE 32
|
The hemodialysis equipment and disposables industry / |
1 |
Y 3.T 22/2:2 C 82/2/case 32
|
The hemodialysis equipment and disposables industry |
1 |
Y 3.T 22/2:2 C 82/2/CASE 33
|
Technologies for managing urinary incontinence / |
1 |
Y 3.T 22/2:2 C 82/2/case 33
|
Technologies for managing urinary incontinence |
1 |